Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel

Clinical Cancer Research

Volumn 9, Issue 1 I, 2003, Pages 363-369

  Chen, Danny ^a   Song, Di ^a   Wientjes, M Guillaume ^a,b   Au, Jessie L S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREMOPHOR; DIMETHYL SULFATE; DOXORUBICIN; MITOMYCIN C; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; GROWTH INHIBITION; MICELLE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; UROTHELIUM;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIMETHYL SULFOXIDE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICELLES; PACLITAXEL; SOLVENTS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0037242323     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Herr, H. W. Intravesical therapy. A critical review. Current Medical Therapy for Urologic Disease. Urol. Clin. N. Am., 14: 399-404, 1987.
2. Chai, M., Wientjes, M. G., Badalament, R. A., Burgers, J. K., and Au, J. L-S. Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients. J. Urol., 153: 374-378, 1994.
3. Dalton, J. T., Wientjes, M. G., Badalament, R. A., Drago, J. R., and Au, J. L-S. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Cancer Res., 51: 5144-5152, 1991.
4. Wientjes, M. G., Dalton, J. T., Badalament, R. A., Drago, J. R., and Au, J. L-S. Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res., 51: 4347-4354, 1991.
5. Wientjes, M. G., Badalament, R. A., Wang, R. C., Hassan, F., and Au, J. L-S. Penetration of mitomycin C in human bladder. Cancer Res., 53: 3314-3320, 1993.
6. Au, J. L-S., Badalament, R. A., Wientjes, M. G., Young, D. C., Warner, J. A., Venema, P. L., Pollifrone, D. L., Harbrecht, J. D., Chin, J. L., Lerner, S. P., and Miles, B. J. Methods to improve efficacy of intravesical mitomycin C: results of a randomized Phase III trial. J. Natl. Cancer Inst. (Bethesda), 93: 597-604, 2001.
7. Rangel, C., Niell, H., Miller, A., and Cox, C. Taxol and taxotere in bladder cancer: in vitro activity and urine stability. Cancer Chemother. Pharmacol., 33: 460-464, 1994.
8. Roth, B. J. Preliminary experience with paclitaxel in advanced bladder cancer. Semin. Oncol., 22: 1-5, 1995.
9. Au, J. L-S., Kalns, J., Gan, Y., and Wientjes, M. G. Pharmacologic effects of paclitaxel in human bladder tumors. Cancer Chemother. Pharmacol., 41: 69-74, 1997.
10. Song, D., Wientjes, M. G., and Au, J. L-S. Bladder tissue pharmacokinetics of intravesical Taxol. Cancer Chemother. Pharmacol., 40: 285-292, 1997.
11. Knemeyer, I., Wientjes, M. G., and Au, J. L-S. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment. Cancer Chemother. Pharmacol., 44: 241-248, 1999.
12. Wood, D. C., and Wood, J. Pharmacologic and biochemical considerations of dimethyl sulfoxide. Ann. N. Y. Acad. Sci., 243: 7-18, 1975.
13. Schoenfeld, R. H., Belville, W. D., Jacob, W. H., Buck, A. S., Dresner, M. L., Insalaco, S. J., and Ward, G. S. The effect of dimethyl sulfoxide on the uptake of cisplatin from the urinary bladder of the dog: a pilot study. J. Am. Osteopath. Assoc., 82: 570-573, 1983.
14. Hashimoto, H., Tokunaka, S., Sasaki, M., Nishihara, M., and Yachiku, S. Dimethyl sulfoxide enhances the absorption of chemotherapeutic drug instilled into the bladder. Urol. Res., 20: 233-236, 1992.
15. See, W. A., and Xia, Q. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. J. Natl. Cancer Inst. (Bethesda), 84: 510-515, 1992.
16. Berne, B., and Pecora, R. Dynamic Light Scattering with Applications to Chemistry, Biology and Physics. New York: Wiley-Interscience, 1976.
17. Wientjes, M. G., Dalton, J. T., Badalament, R. A., Dasani, B. M., Drago, J. R., and Au, J. L-S. A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall. Pharm. Res. (N. Y.), 8: 168-173, 1991.
18. Gao. X., Au, J. L., Badalament, R. A., and Wientjes, M. G. Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine. Clin. Cancer Res., 4: 139-143, 1998.
19. Song, D., and Au, J. L. Isocratic high-performance liquid chromatographic assay of Taxol in biological fluids and tissues using automated column switching. J. Chromatogr. B., Biomed. Appl., 663: 337-344, 1995.
20. Huizing, M. T., Keung, A. C. F., and Rosing, H. Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J. Clin. Oncol., 11: 2127-2135, 1993.
21. Jacob, S. W., and Herschler, R. Pharmacology of DMSO. Cryobiology, 23: 14-27, 1986.
22. Rijtema, M., Mosig, D., Drukker, A., and Guignard, J. P. The effects of dimethyl sulfoxide on renal function of the newborn rabbit. Biol. Neonate, 76: 355-361, 1999.
23. Turnbull, G. J. Ultrastructural basis of the permeability barrier in urothelium. Investig. Urol., 11: 198-204, 1973.
24. Hicks, R. M., Ketterer, B., and Warren, R. C. The ultrastructure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. Philos. Trans. R. Soc. Lond-Biol. Sci., 268: 23-38, 1974.